Keep Up With McLean!
Receive the latest news in your inbox each month.
At McLean Hospital, we know that addiction to alcohol, opiates, and other substances is a complex mental health condition, one that is often accompanied by other symptoms and conditions.
We are committed to helping adults recover from substance use disorders and other coexisting mental health conditions like depression and anxiety.
If you have gone through detoxification and need the benefit of additional treatment in a structured environment, the Ambulatory Treatment Center at Naukeag may be right for you.
Located northwest of Boston in Petersham, Massachusetts, our insurance-based program provides residential and partial hospital substance use disorder care.
The Ambulatory Treatment Center at Naukeag is ideal for adults who:
Naukeag is nestled in a quiet community. The program facilities offer comfortable bedrooms, common areas for groups and conversation, and beautiful grounds.
Learn more about addiction care at McLean Hospital.
Our highly-skilled clinicians and support staff provide exceptional care for individuals addicted to drugs and/or alcohol, with or without other coexisting mental health conditions.
Care at Naukeag focuses on group and individual therapy, as well as medication consultations as may be appropriate. We utilize behavioral therapies such as cognitive behavior therapy and integrated group therapy.
We work with patients to develop tailored treatment plans that puts individuals on the path to recovery by offering support as they reclaim their independence from addictive substances, learn to manage the stress of an active life without returning to drug and alcohol dependence, and attain personal, career, and recovery goals.
Tobacco use is addressed as a substance use disorder and patients are encourage to quit as part of recovery. Nicotine cessation treatment, including medications and behavioral interventions, is available. Tobacco products are not allowed inside the buildings, though there is one designated smoking area outside. Cigars, chewing tobacco, and e-cigarettes are not allowed on the premises.
Program features include:
The Ambulatory Treatment Center at Naukeag is ideal for individuals who have gone through detoxification and need the benefit of additional treatment in a structured environment.
For further information about our program or to make a referral, please contact our admissions coordinator:
McLean accepts Medicare, Massachusetts Medicaid, and many private insurance and managed care plans. Insurance coverage may be limited for some services, especially for longer-term residential treatment.
More information on insurance providers accepted by McLean Hospital may be found on the Partners HealthCare website. You may also find it beneficial to review McLean’s patient billing and financial assistance information.
William Krauss, LMHC, LCSW, LADCI, Program Director
Mr. Krauss has expertise in integrated dual diagnosis treatment, an evidence-based model that addresses a person’s substance use in the context of the treatment of their mental illness. He also has experience providing addiction treatment for many underserved populations: the homeless, HIV-positive individuals, women and their children, adolescents, and those with severe and persistent mental illness.
Andrew D. Gill, MD, Medical Director
Dr. Gill has been the medical director at the Ambulatory Treatment Center at Naukeag since its opening. He is also a consulting psychiatrist at Fernside, a McLean Hospital Signature Addiction Recovery Program. In addition to previous years spent on the staff at Beth Israel Hospital in Boston, Dr. Gill has worked at several non-profit clinics and hospitals in central Massachusetts.
Monika Kolodziej, PhD, Director of Psychological Services
Dr. Kolodziej’s clinical, research, and program evaluation activities focus on services for individuals diagnosed with co-occurring psychiatric and substance use disorders, both of which are often accompanied by chronic medical conditions. She is especially interested in implementing effective tools to track and improve treatment outcomes, and in exploring means to increase collaboration between multidisciplinary providers, patients, and their families.
Hilary S. Connery, MD, PhD, Clinical Director, Substance Use Disorders Division
Dr. Connery’s expertise includes the treatment of opioid use disorders and co-occurring psychiatric and substance use disorders. She was a contributor to the APA Practice Guidelines for the treatment of substance abuse and is an investigator in the New England Consortium of the NIDA Clinical Trials Network. Dr. Connery is also the addiction psychiatry rotation director for the MGH/McLean Adult Psychiatry Residency Training Program.
Roger D. Weiss, MD, Senior Consultant
Currently chief of McLean’s Substance Use Disorders Division, Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has authored over 300 publications, including several books, and is the recipient of numerous National Institutes of Health grants for developing integrated group therapy, as well as leading a multisite treatment study of prescription opioid dependence.
Shelly F. Greenfield, MD, MPH, Senior Consultant
Dr. Greenfield is an addiction psychiatrist, clinician, and researcher. Her research focuses on treatment, gender differences, and health services as relates to substance use. She is a recipient of National Institute on Drug Abuse (NIDA) funding for mentoring in substance use disorder patient oriented research as well as for developing and testing a new manual-based group therapy for women with substance use disorders.
Nancy Merrill, PMHCNS, BC, Senior Consultant
A board certified advanced practice psychiatric nurse for more than 30 years, Ms. Merrill has been working in McLean’s Substance Use Disorders Division for the past 20 years and is currently program director of the Alcohol and Drug Abuse Inpatient Program. During her time at McLean, she has been involved in several national research projects including the COMBINE study, the Topamax medication study, and the integrated group therapy study.
Our staff consists of a multidisciplinary group of board-certified psychiatrists, licensed clinical social workers, registered nurses, and expressive therapists. This highly trained and experienced team provides rapid, accurate diagnosis, thorough treatment planning, aftercare planning and high-quality care tailored to each individual’s needs.
Naukeag staff have experience working with patients from diverse cultural and socioeconomic backgrounds.
The Ambulatory Treatment Center at Naukeag is part of the Substance Use Disorders Division led by Roger D. Weiss, MD.
Located in central Massachusetts, the Ambulatory Treatment Center at Naukeag offers a serene setting that allows patients the opportunity to focus on treatment and recovery.
Accommodations at Naukeag include comfortable, private bedrooms and common areas with ample room for both group therapy and leisure time. Patients have access to an onsite fitness center as well as games and activities.
The wooded grounds at Naukeag are ideal for quiet reflection and outdoor activities.
The program is located in Petersham, Massachusetts. For more information on directions, parking, and local accommodations, please visit our Maps & Directions page.
Our residential and partial hospital program focuses on treating individuals with serious substance use conditions who are stable, post detox, have manageable mental health and physical symptoms, who want and agree to come to rehab, and are motivated for treatment.
Family involvement is strongly recommended. With permission of the patient, family members can be involved in assessment and in treatment/aftercare planning.
At Naukeag, we address tobacco use as a substance use disorder and encourage patients to quit. Nicotine cessation treatment, including medications and behavioral interventions, is available. Tobacco products are not allowed inside the buildings, though there is one designated smoking area outside. Cigars, chewing tobacco, and e-cigarettes are not allowed on the premises.
Visiting hours are 2-4pm Monday through Saturday and 12-4pm Sunday.
Patients are allowed to hold and use their cell phones, except during therapy (individual and group), with some guidelines to prevent disruption of the program and other patients. Cell phones may be taken away if they interfere with treatment.
The treatment team works closely with the individual as well as with family, significant friends, and outside providers to develop a personalized aftercare plan. Recommendations by staff are made based upon clinical needs, progress made during treatment, and long-term treatment goals.
All requests for medical records should be directed to McLean’s Health Information Management Department.
To complement our programs’ services and encourage individuals’ initiatives in their own treatment course, many self-help groups are hosted by McLean.
McLean is dedicated to maintaining high-quality and effective patient care. To ensure that those standards remain at the highest level, we utilize a number of feedback instruments and quality indicators. Among these tools are the Perceptions of Care survey which monitors patient satisfaction and BASIS-24™, a psychiatric outcomes measurement tool created at McLean and widely used in the US and around the world, which delivers feedback on the patient care experience.